comparemela.com

Latest Breaking News On - Oncologic sciences - Page 1 : comparemela.com

Dr Eroglu on Addressing Unmet Needs in Mutant Melanoma

Zeynep Eroglu, MD, discusses a phase 1/2 trial that evaluated ceritinib alone and in combination with trametinib in patients with mutant melanoma.

Zeynep-eroglu
Moffitt-cancer-center
Department-of-oncologic-sciences
Department-of-cutaneous-oncology
Cutaneous-oncology
Oncologic-sciences
South-florida-morsani-college
Moffitt-cancer-center
Melanoma-amp-skin-cancer
Onclive-tv

Dr Eroglu on Ceritinib With or Without Trametinib in Pretreated Advanced Melanoma

Zeynep Eroglu, MD, discusses the efficacy and safety of ceritinib as monotherapy and in combination with trametinib in pretreated advanced melanoma.

Zeynep-eroglu
Department-of-cutaneous-oncology
Moffitt-cancer-center
Department-of-oncologic-sciences
Cutaneous-oncology
Oncologic-sciences
South-florida-morsani-college
Pretreated-advanced-melanoma
Trametinib
Ceritinib

Comprehensive Review Highlights Potential Benefits of Leukine® in Management of Gastrointestinal (GI) Adverse Events Associated with Immune Checkpoint Inhibitors (ICIs) in the Treatment of Cancer

NCI sponsored, ECOG-ACRIN Phase 3 Study of Leukine in Combination with Ipilimumab and Nivolumab in Front Line Treatment of Melanoma Heads to Last Stages of Enrollment

United-states
Massachusetts
Dana-farber-cancer-institute
American
Ahmada-tarhini
F-stephen-hodi-jr
H-lee-moffitt-cancer-center
Professor-of-oncologic-sciences
Melanoma-committee
Tanner-pharma-group
Prnewswire-partner-therapeutics-inc

Toxicities Hinder Potential Efficacy of Ceritinib/Trametinib in Pretreated Advanced Melanoma

Zeynep Eroglu, MD, discusses how findings from a phase 1/2 study of ceritinib and trametinib could help inform future research in melanoma.

Zeynep-eroglu
Keiran-smalley
Moffitt-cancer-center
Department-of-oncologic-sciences
Cutaneous-oncology
Oncologic-sciences
South-florida-morsani-college
Melanoma
Ceritinib-and-trametinib-
D
Taacr

Dr Eroglu on the Safety Profile of Ceritinib Plus Trametinib in Advanced Melanoma

Zeynep Eroglu, MD, discusses the safety profile of ceritinib plus trametinib in pretreated metastatic melanoma.

Zeynep-eroglu
University-of-south-florida
Moffitt-cancer-center
Department-of-oncologic-sciences
Department-of-cutaneous-oncology
Morsani-college-of-medicine
Cutaneous-oncology
Oncologic-sciences
South-florida
Morsani-college
Melanoma
Skin-cancer

vimarsana © 2020. All Rights Reserved.